The RTOG Foundation Communications Committee is searching for communications interns! This will be a 12-month internship, ideal for radiation oncology residents looking for ways to get involved with cancer research and other organizational activities. Interns will work with RTOG communications staff to create social media content around RTOG Foundation trials. Interns will attend virtual meetings with the communications team, RTOG Foundation Board meetings, and will also have the opportunity to attend an RTOG investigators meeting. There will be a $1,000 stipend for each intern. 

Please contact info@rtog.org for questions. 

Please submit a cover letter and your CV to info@rtog.org by APRIL 1, 2024.

Danielle Cerbon, MD, was selected to be one of two 2023 RTOG Foundation Communications Interns. This position began in July 2023 and will continue through July 2024. Dr. Cerbon is a PGY-4 radiation oncology resident at the University of Miami Sylvester Cancer Center and Jackson Memorial Hospital. She is currently chief resident at her residency program, as well as Chair of the Communications Committee for the Society for Women in Radiation Oncology (SWRO) where she oversees the organization’s social media platforms, website, and blog and helped launch SWRO’s Instagram account as well as produce all of their graphic designs. She is also part of the American College of Radiation Oncology (ACRO) Resident communication subcommittee where she helps with managing their Instagram account.

Rituraj Upadhyay, MD, was selected to be one of two 2023 RTOG Foundation Communications Interns. This position began in July 2023 and will continue through July 2024. Dr. Upadhyay is currently the chief resident in the Department of Radiation Oncology at The Ohio State University Arthur G. James Cancer Hospital. He is also a member of the Association of Residents in Radiation Oncology (ARRO) communications and global health subcommittee as well as a Radiological Society of North American (RSNA) resident representative for 2023. Dr. Upadhyay expressed that he believes effective communication plays a vital role in trial enrollment as well as shaping public perception and behavior towards cancer care.

Shearwood ‘Woody’ McClelland III, MD is the Director of Spine Oncology in the Department of Radiation Oncology at the University Hospitals Seidman Cancer Center and Assistant Professor of Radiation Oncology and Neurological Surgery at Case Western Reserve University School of Medicine. Dr. McClelland’s work focuses on radiation-based modalities for treating central nervous system disease with an emphasis on investigating disparities in healthcare access. He led the first nationwide analysis of spine stereotactic body radiation therapy (SBRT) utilization in the United States and has authored numerous published articles in peer-reviewed journals. Dr. McClelland is the Principal Investigator of an ongoing Phase II neuro-oncology randomized controlled trial, and his research (TheMcClellandLab.com) has been funded for a total of $1.4 million by several agencies including the National Institutes of Health, Susan G Komen, Bristol Myers Squibb Foundation, American Society for Radiation Oncology, and Gilead Sciences.